NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Hybrid Assistive Limb Application in Multiple Sclerosis Patients

CompletedNA

Sponsor: Ege University

Conditions: Multiple Sclerosis

Interventions: Hybrid Assistive Limb (HAL)

Countries: Turkey (Türkiye)

The Hybrid Assistive Limb (HAL) exoskeleton detects bioelectrical signals from the muscles, responds to the intention of voluntary movement, and provides biological feedback. In this study, the effects of HAL application on walking performance and balance in patients with multiple sclerosis will be examined in a single-center, controlled design. Participants will undergo walking rehabilitation with HAL for 1 hour per day, 5 days a week, for a total of 2 months. Walking and balance performance will be assessed before and after the intervention using the 10-Minute Walk Test (10MWT) to measure maximum walking speed, the 6-Minute Walk Test (6MWT) to evaluate walking endurance and cardiorespiratory performance, and the Timed Up and Go Test (TUG) to assess functional mobility and dynamic balance. Additionally, walking parameters and static balance will be measured using Tecnobody systems. Appropriate statistical tests will be applied, and a significance level of p\<0.05 will be considered.

Eligibility overview

Sex: ALL

Age: 18 Years to 50 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* No previous robotic rehabilitation.
* Completion of the 10-meter walk test.
* Mini mental status score ≥24.
* MASS score \<2.
* EDSS \<6.

Exclusion Criteria:

* History of serious degenerative disease.
* Presence of open wounds.
* History of thoracic surgery.
* Chronic respiratory diseases.
* Presence of unstable cardiovascular disease.
* Medical conditions that prevent mobilization.

Locations (1)

Izmir, Karşıyaka, Turkey (Türkiye)